Quick Answer
Estrogen withdrawal triggers migraine — menopause can improve or worsen attacks depending on the transition pattern.
Medically reviewed by Dr. Jitendra Prasad Yadav • NMC 8029 • Kathmandu Neurology Clinic & Cognitive Center
For women with migraine, hormonal fluctuations are among the most powerful triggers. Menstrual cycles, pregnancy, and menopause all influence attack frequency through effects on estrogen levels.
The estrogen-migraine connection
Estrogen influences migraine through trigeminal sensitization, serotonin effects, inflammatory modulation, and CGRP interaction. The key pattern is estrogen withdrawal: attacks are triggered by rapid estrogen decline, not high levels. This explains menstrual migraine (pre-menstrual drop) and why menopause produces variable effects.
Menopause stages and migraine
Perimenopause (the transition)
Perimenopause (4-8 years before menopause) involves irregular cycles and fluctuating estrogen. This is often the most difficult period: estrogen swings dramatically, cycles become unpredictable, attacks may increase in frequency and severity, and menstrual migraine may transform into non-menstrual or chronic patterns.
Menopause (12 months without periods)
After menopause, estrogen stabilizes at low levels. For ~60-70% of women, migraine improves significantly. However, ~30% continue to have migraine or develop new-onset attacks, especially those with severe premenopausal migraine, chronic migraine, HRT use, or obesity.
Hormone replacement therapy and migraine
- Transdermal estrogen (patch, gel): stable levels, preferred for migraine patients.
- Oral estrogen: peaks and troughs that can trigger attacks.
- Continuous versus cyclic: continuous HRT (no withdrawal bleed) is better.
- Aura caution: HRT requires additional caution for migraine with aura due to stroke risk.
HRT decisions should be individualized with gynecology and neurology input.
Non-hormonal management
- Preventive medications: beta-blockers, anticonvulsants, antidepressants, CGRP antibodies.
- Acute treatment optimization: triptans, gepants, NSAIDs with appropriate limits.
- Non-pharmacological: sleep regularity, stress management, exercise.
- Botox: for chronic migraine (≥15 headache days/month).
When to seek evaluation
- New or worsening headaches during perimenopause.
- Headache pattern changing significantly.
- Migraine not responding to usual treatments.
- Considering HRT with migraine with aura.
- Headaches affecting daily function during menopause.
Menopause is a neurological transition, not just reproductive. At Kathmandu Neurology Clinic & Cognitive Center, Dr. Jitendra Prasad Yadav (NMC 8029) provides individualized migraine management during perimenopause and menopause, coordinating with gynecology when HRT is considered.
This article is educational and does not replace individual medical advice.
Migraine vs Other Headaches — Quick Comparison
| Feature | Migraine | Tension-Type |
|---|---|---|
| Pain | Throbbing, often one-sided | Pressure, band-like, bilateral |
| Severity | Moderate–severe | Mild–moderate |
| Other | Nausea, photophobia, aura | No nausea/vomiting, mild photophobia only |
Table for comprehension — see Migraine guide → for full criteria.
Frequently asked questions
Answers reviewed by Dr. Jitendra Prasad Yadav • MBBS, MD (Internal Medicine), FICN (Neurology), FCNV, FIHM • NMC 8029
Migraine is a neurological condition; headache is one feature. Associated symptoms and functional impact are important for diagnosis.
Aura refers to visual, sensory, or speech symptoms that precede the headache in some people. Both types are migraine; the presence of aura may influence management discussion.
Frequency may improve with systematic evaluation of types, contributors, and individualized planning, but outcomes vary.
Using pain medication on 10+ days per month can trigger daily headache. Reduction or cessation under medical supervision may help break this cycle.
Migraine typically presents as moderate-severe throbbing headache with nausea and/or sensitivity to light or sound, worsened by routine activity. Duration 4–72 hours. Dr. Jitendra Prasad Yadav (NMC 8029) uses ICHD-3 criteria plus your headache diary (frequency, aura, medication days) and red-flag screen to distinguish …
Prevention is discussed after 4–8 weeks of diary shows ≥8 migrainous days/month or medication-overuse pattern. Options include lifestyle regularity, comorbidity treatment and preventive medicines selected per history and contraindications. No preventive works instantly; follow-up with the same consultant tracks days/mo…
More: All FAQs → · Ask Dr. Jitendra →
Related articles
Understanding Migraine Triggers: What to Track and How
Learn how to identify personal migraine triggers, use a headache diary effectively, and discuss patterns with your clinician.
Migraine vs Ordinary Headache: How to Tell the Difference
Migraine is more than a strong headache —— timing, associated symptoms, and disability distinguish it from tension-type and cluster headache.
Migraine Treatment Options in Kathmandu —— Acute, Preventive and Diary-Based
Migraine treatment in Kathmandu: acute stewardship, preventive thresholds and diary-based follow-up with Dr. Jitendra (NMC 8029).
Medical Disclaimer
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.
References & Review
Reviewed by Dr. Jitendra Prasad Yadav • Last reviewed: 2026-11-10
- International Classification of Headache Disorders, 3rd edition (ICHD-3).
- Harrison's Principles of Internal Medicine — Neurology sections.
- American Academy of Neurology guidelines for selected conditions (where applicable).
Content is educational and aligns with standard medical references; individual evaluation may vary. External links provide context and do not imply endorsement.